Literature DB >> 26370487

[Eosinophilic pleuritic: An unusual complication of treatment with an angiotensin converting enzyme inhibitor].

A Zouak1, É Bongrain2, C Launois1, J Nardi1, J Vella-Boucaud1, G Deslee1, F Lebargy1, J-M Perotin3.   

Abstract

BACKGROUND: Eosinophilic pleural effusions are defined by an eosinophil count ≥10% in pleural fluid and represent approximately 10% of exudative pleural effusions. OBSERVATION: We report the first case of eosinophilic pleural effusion occurring due to lisinopril treatment. Improvement after drug discontinuation and recurrence after reintroduction indicated that lisinopril was responsible for the effusion.
CONCLUSION: The main causes of eosinophilic pleural effusions are infections including tuberculosis, and malignancies. Drug-induced eosinophilic pleural effusions have only rarely been described, mainly caused by cardiovascular or neuropsychiatric medicines.
Copyright © 2014 SPLF. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Angiotensin converting enzyme inhibitor; Eosinophilic pleural effusion; Iatrogenic pleural effusion; Inhibiteur de l’enzyme de conversion de l’angiotensine; Lisinopril; Pleural fluid; Pleurésie iatrogène; Pleurésie à éosinophile; Épanchement pleural

Mesh:

Substances:

Year:  2014        PMID: 26370487     DOI: 10.1016/j.rmr.2014.08.004

Source DB:  PubMed          Journal:  Rev Mal Respir        ISSN: 0761-8425            Impact factor:   0.622


  1 in total

1.  Olanzapine-induced peripheral eosinophilia and eosinophilic pleural effusion: A case report.

Authors:  Jing Huang; Yiming Yu; Wei Lin; Dandan Zhang; Zaichun Deng; Qunli Ding
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.